Use of the hypertensive agent angiotensin II for modifying oxygen delivery to tumours.
Tozer
G M
GM
CRC Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex.
Shaffi
K M
KM
Hirst
D G
DG
D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D008297:Male; D010100:Oxygen / Q000378:metabolism*; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012513:Sarcoma, Experimental / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
D000804:Angiotensin II; D010100:Oxygen